Zobrazeno 1 - 10
of 606
pro vyhledávání: '"Rigas, B."'
Publikováno v:
In Digestive and Liver Disease 2003 35 Supplement 2:S27-S34
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
British Journal of Cancer. 3/24/2008, Vol. 98 Issue 7, p1157-1160. 4p. 1 Diagram, 1 Chart.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Immunology. Oct94, Vol. 83 Issue 2, p319-323. 5p.
Phospho-ibuprofen (P-I; MDC-917) inhibits the growth of colon cancer in mice. Here, we investigated the use of nanocarriers to improve its pharmacokinetics (PKs) and anti tumour efficacy.The cellular uptake and cytotoxicity of P-I encapsulated into l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2cdd88cfd789d46776c47bcfcbebe0e
https://europepmc.org/articles/PMC3417424/
https://europepmc.org/articles/PMC3417424/
Autor:
Xie, G, Nie, T, Mackenzie, GG, Sun, Y, Huang, L, Ouyang, N, Alston, N, Zhu, C, Murray, OT, Constantinides, PP, Kopelovich, L, Rigas, B
Phospho-sulindac (PS; OXT-328) prevents colon cancer in mice, especially when combined with difluoromethylornithine (DFMO). Here, we explored its metabolism and pharmacokinetics.PS metabolism was studied in cultured cells, liver microsomes and cytoso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ab0a604aac7f469874a2985db54cdde
https://europepmc.org/articles/PMC3413853/
https://europepmc.org/articles/PMC3413853/
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in the treatment of rheumatoid arthritis (RA) is limited by their toxicity. We evaluated the anti-inflammatory efficacy and safety of three novel modified NSAIDs, phospho-aspirin, phospho-ibup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab18e5d2d74496df6348503b31af340a
https://europepmc.org/articles/PMC3057290/
https://europepmc.org/articles/PMC3057290/
Nitric oxide-donating nonsteroidal anti-inflammatory drugs (NO-NSAIDs) represent a novel class of compounds that hold promise as agents for the control of colon cancer. They are derivatives of conventional NSAIDs that have been modified by adding to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::df74d851cf4101a3902705d1ff5af95e
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062529
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3062529